产品
编 号：F370223
分子式：C17H15NO5
分子量：313.3
分子式：C17H15NO5
分子量：313.3
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
500mg
240
In-stock
1g
360
In-stock
5g
720
In-stock
结构图
CAS No: 5003-48-5
产品详情
生物活性：
Benorylate (Salipran) is the esterification product of paracetamol and acetylsalicylic acid. Benorylate has anti-inflammatory, analgesic and antipyretic properties. Benorylate could also inhibit prostaglandin (PG) synthesis.
体内研究：
Benorylate (Salipran) is probably absorbed as the intact molecule which accounts for its good gastric tolerance. Benorylate (Salipran) could inhibit PG synthesis in laboratory animals and in human tissue.
体外研究：
Benorylate (Salipran) is an esterified aspirin preparation whose antirheumatic properties are reported to be as good as those of aspirin.Benorylate (Salipran) causes a large decrease in the liver’s conversion rate of lactate into glucose, an important component of glucose homeostasis. Benorylate (Salipran) also impairs the urea synthesis rate from ammonia, another important function of the liver.
Benorylate (Salipran) is the esterification product of paracetamol and acetylsalicylic acid. Benorylate has anti-inflammatory, analgesic and antipyretic properties. Benorylate could also inhibit prostaglandin (PG) synthesis.
体内研究：
Benorylate (Salipran) is probably absorbed as the intact molecule which accounts for its good gastric tolerance. Benorylate (Salipran) could inhibit PG synthesis in laboratory animals and in human tissue.
体外研究：
Benorylate (Salipran) is an esterified aspirin preparation whose antirheumatic properties are reported to be as good as those of aspirin.Benorylate (Salipran) causes a large decrease in the liver’s conversion rate of lactate into glucose, an important component of glucose homeostasis. Benorylate (Salipran) also impairs the urea synthesis rate from ammonia, another important function of the liver.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备